articleThe LancetJan 24, 2022GREEN OA

Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

CCCharles C WykoffFAFrancis AbreuAPAnthony P AdamisKBKaren BasuDADavid A Eichenbaum

Roche (Ireland) · Tel Aviv University · +6 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

423
total citations
FWCI
76.49
Percentile
100%
References
25
Citations per year

Authors

394
  • CC
    Charles C WykoffCorresponding
  • FA
    Francis Abreu
  • AP
    Anthony P Adamis
  • KB
    Karen Basu

    Roche (Ireland)

  • DA
    David A Eichenbaum

Topics & keywords

Topics
Keywords
  • Dosing
  • Clinical trial
  • Diabetic retinopathy
  • Diabetic macular edema
  • Diabetes mellitus
No related works found for this paper.

Funding